Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

When researchers offer data suggesting a personalized vaccine might be able to keep the cancer at bay for years, it’s worth ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...

A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...

Understanding your tumor biology is key to finding the right treatment for pancreatic cancer. Identifying mutations, or changes in a [...] READ MORE ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems from both late detection ...

This month’s Research Spotlight highlights significant advancements in pancreatic cancer research and patient support.